Resources
The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Human Services Catalog
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Operational Procedures
Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers in Immuno-Oncology
NeoGenomics: Transforming Care for Cancer Patients
Comprehensive service overview for pharmaceutical partners
Biomarkers in Immuno-Oncology
SyncroPatch 384 For All Your Patch Clamp Needs
Unprecedented flexibility for HTS automated patch clamp.
Biomarkers in Immuno-Oncology
Nanion: Cell Analytics Brochure
Next level live-cell kinetic and phenotypic assays.
Biomarkers in Immuno-Oncology
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
Biomarkers in Immuno-Oncology
Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time
Nanion Technologies GmbH, Munich. TUM, Munich
Biomarkers in Immuno-Oncology
Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities
The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
Biomarkers in Immuno-Oncology
A ‘New Age’ of Biomarker Technology? Understanding Identification & Validation of IO Biomarkers
Developing and validating IO biomarkers present challenges, such as working with challenging sample types, interpreting sequencing data, and integrating new technologies into the clinic.
Biomarkers in Immuno-Oncology
Axion Biosystems: Organoid Analysis Module
Robust organoid quantification and monitoring.
Biomarkers in Immuno-Oncology
Volition: Nu.Q Discover
An innovative solution to profiling nucleosomes.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno